CUSIP 45826J105COMNTLAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
288 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ark Investment Management LLC | 14.21M | $127.72M | +2.29M | Added |
| 2 | Vanguard Group Inc | 13.01M | $116.96M | +1.97M | Added |
| 3 | Blackrock, Inc. | 10.28M | $92.39M | +1.00M | Added |
| 4 | State Street Corp | 6.42M | $57.71M |
| Added |
| 5 | D. E. Shaw & Co., Inc. | 5.33M | $47.93M | +3.10M | Added |
| 6 | Regeneron Pharmaceuticals, Inc. | 3.70M | $33.29M | 0 | Held |
| 7 | Two Sigma Investments, LP | 2.70M | $24.26M | +249.1K | Added |
| 8 | Geode Capital Management, LLC | 2.70M | $24.24M | +107.3K | Added |
| 9 | Two Sigma Advisers, LP | 2.35M | $21.09M | +182.9K | Added |
| 10 | Morgan Stanley | 2.33M | $20.93M | −3.69M | Reduced |
See every fund holding Intellia Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders